Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC..
Filing timeline
BuySaleJeffrey A. Munsie
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeffrey A. Munsie: trading record in brief
Jeffrey A. Munsie, listed as senior executive, appears in our data through filings on Concert Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 February 2020 to 6 March 2023, the count stands at 11 filings.
On the market, this insider has only sold: 6 sales, €156k in total. Other entries cover 3 share grants. Since January 2023: no purchases and 3 sales on the market.
The record was last updated on 6 March 2023 with a transaction in Concert Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey A. Munsie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
38,350 sharesCommon StockSEC:0001209191-23-016167:0
3,762 shares@ US$8.3420.7% of flowCommon StockSEC:0001209191-23-009950:0
8,493 shares@ US$8.3546.3% of flowCommon StockSEC:0001209191-23-005621:0
2,893 shares@ US$7.2514.1% of flowCommon StockSEC:0001209191-23-002553:0
3,762 shares@ US$3.097.7% of flowCommon StockSEC:0001209191-22-010073:0
63,700 sharesCommon StockSEC:0001209191-22-005880:0
2,894 shares@ US$3.206.2% of flowCommon StockSEC:0001209191-22-002402:0
7 of 7 declarations
